I think things will liven up when they announce the trial conditions and start date. I am guessing the trial will be around 385 patients based on a 95% confidence level. If it is, i think the market will look at it very favourably, especially if we get $25k reimbursement and continued sales post final operation. Continued sales is extremely good as a 1 year wait from last operation to fda approval with nothing in between would see a decent drift in share price.
I think things will liven up when they announce the trial...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
-0.500(3.19%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $294.3K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1135 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |